Vitrolife AB (VITR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vitrolife AB (VITR) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr172.00 Million ≈ $18.51 Million USD) by net assets (Skr8.07 Billion ≈ $868.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Vitrolife AB (VITR) defensive interval to measure how many days the company can operate on defensive assets alone.
Vitrolife AB - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Vitrolife AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Vitrolife AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vitrolife AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
M Yochananof and Sons Ltd
TA:YHNF
|
0.068x |
|
Polestar Automotive Holding UK PLC Class A ADS
NASDAQ:PSNY
|
0.058x |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
|
0.018x |
|
Shandong Yisheng Livestock & Poultry Breeding Co Ltd
SHE:002458
|
0.021x |
|
Zhiyang Innovation Technology Co. Ltd. A
SHG:688191
|
-0.026x |
|
Paymentus Holdings, Inc.
NYSE:PAY
|
0.052x |
|
Zhejiang Huangma Technology Co Ltd
SHG:603181
|
0.043x |
|
Alimak Hek Group AB
ST:ALIG
|
0.115x |
Annual Cash Flow Conversion Efficiency for Vitrolife AB (2002–2025)
The table below shows the annual cash flow conversion efficiency of Vitrolife AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Vitrolife AB (VITR) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr7.89 Billion ≈ $849.63 Million |
Skr635.00 Million ≈ $68.34 Million |
0.080x | +20.97% |
| 2024-12-31 | Skr13.64 Billion ≈ $1.47 Billion |
Skr907.00 Million ≈ $97.61 Million |
0.066x | +11.75% |
| 2023-12-31 | Skr12.72 Billion ≈ $1.37 Billion |
Skr757.00 Million ≈ $81.47 Million |
0.059x | +56.60% |
| 2022-12-31 | Skr16.74 Billion ≈ $1.80 Billion |
Skr636.00 Million ≈ $68.44 Million |
0.038x | +51.66% |
| 2021-12-31 | Skr15.34 Billion ≈ $1.65 Billion |
Skr384.31 Million ≈ $41.36 Million |
0.025x | -85.82% |
| 2020-12-31 | Skr2.02 Billion ≈ $217.06 Million |
Skr356.45 Million ≈ $38.36 Million |
0.177x | -23.14% |
| 2019-12-31 | Skr1.80 Billion ≈ $193.45 Million |
Skr413.33 Million ≈ $44.48 Million |
0.230x | -1.55% |
| 2018-12-31 | Skr1.50 Billion ≈ $161.02 Million |
Skr349.44 Million ≈ $37.60 Million |
0.234x | -8.09% |
| 2017-12-31 | Skr1.23 Billion ≈ $132.22 Million |
Skr312.19 Million ≈ $33.60 Million |
0.254x | +43.04% |
| 2016-12-31 | Skr1.02 Billion ≈ $109.81 Million |
Skr181.26 Million ≈ $19.51 Million |
0.178x | -22.44% |
| 2015-12-31 | Skr844.97 Million ≈ $90.93 Million |
Skr193.53 Million ≈ $20.83 Million |
0.229x | +10.47% |
| 2014-12-31 | Skr702.57 Million ≈ $75.61 Million |
Skr145.67 Million ≈ $15.68 Million |
0.207x | -36.98% |
| 2013-12-31 | Skr322.60 Million ≈ $34.72 Million |
Skr106.13 Million ≈ $11.42 Million |
0.329x | +53.14% |
| 2012-12-31 | Skr278.98 Million ≈ $30.02 Million |
Skr59.93 Million ≈ $6.45 Million |
0.215x | +87.22% |
| 2011-12-31 | Skr343.90 Million ≈ $37.01 Million |
Skr39.46 Million ≈ $4.25 Million |
0.115x | -22.63% |
| 2010-12-31 | Skr326.33 Million ≈ $35.12 Million |
Skr48.40 Million ≈ $5.21 Million |
0.148x | +11.59% |
| 2009-12-31 | Skr312.07 Million ≈ $33.58 Million |
Skr41.48 Million ≈ $4.46 Million |
0.133x | -9.19% |
| 2008-12-31 | Skr292.39 Million ≈ $31.47 Million |
Skr42.79 Million ≈ $4.61 Million |
0.146x | +74.23% |
| 2007-12-31 | Skr253.38 Million ≈ $27.27 Million |
Skr21.29 Million ≈ $2.29 Million |
0.084x | -22.07% |
| 2006-12-31 | Skr220.64 Million ≈ $23.74 Million |
Skr23.78 Million ≈ $2.56 Million |
0.108x | +34.70% |
| 2005-12-31 | Skr176.45 Million ≈ $18.99 Million |
Skr14.12 Million ≈ $1.52 Million |
0.080x | -13.96% |
| 2004-12-31 | Skr150.57 Million ≈ $16.20 Million |
Skr14.01 Million ≈ $1.51 Million |
0.093x | -57.25% |
| 2003-12-31 | Skr143.44 Million ≈ $15.44 Million |
Skr31.20 Million ≈ $3.36 Million |
0.218x | -30.30% |
| 2002-12-31 | Skr111.40 Million ≈ $11.99 Million |
Skr34.77 Million ≈ $3.74 Million |
0.312x | -- |
About Vitrolife AB
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more